Phase II Trial of Allovectin-7® for Head and Neck Cancer
NCT00050388
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Head and Neck Cancer
Squamous Cell Carcinoma of the Oral Cavity or Oropharynx
Head and Neck Neoplasms
Carcinoma of the Head and Neck
Interventions
GENETIC:
Allovectin-7®
Sponsor
Vical